0.6280
-0.0110
(-1.72%)
At close: April 3 at 4:00:02 PM EDT
0.6550
+0.03
+(4.30%)
Pre-Market: 8:11:57 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.03 | -0.05 | -0.18 | 0.17 |
| Low Estimate | -0.03 | -0.05 | -0.18 | 0.17 |
| High Estimate | -0.03 | -0.05 | -0.18 | 0.17 |
| Year Ago EPS | -- | -- | -0.08 | -0.18 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | 10.28M |
| Low Estimate | -- | -- | -- | 10.28M |
| High Estimate | -- | -- | -- | 10.28M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
Earnings History
| Currency in USD | 9/30/2024 | 12/31/2024 |
|---|---|---|
| EPS Est. | -0.02 | -0.02 |
| EPS Actual | -0.02 | -0.05 |
| Difference | 0 | -0.03 |
| Surprise % | 0.00% | -150.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.03 | -0.05 | -0.18 | 0.17 |
| 7 Days Ago | -0.03 | 0.02 | -0.11 | 0.17 |
| 30 Days Ago | -0.03 | 0.02 | -0.11 | 0.17 |
| 60 Days Ago | -0.03 | 0.02 | -0.11 | 0.17 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| JUNS | -- | -- | -125.00% | 194.44% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Related Tickers
EXOZ eXoZymes, Inc.
10.44
+3.16%
PLRZ Polyrizon Ltd.
0.3590
-8.42%
MAZE Maze Therapeutics, Inc.
9.32
-10.13%
AVBP ArriVent BioPharma, Inc.
16.94
-5.89%
KAPA Kairos Pharma, Ltd.
0.9400
+2.34%
QUIA.ST Quia Pharma AB (publ)
0.0101
+74.14%
IMMU.ST Mendus AB (publ)
5.38
-3.24%
FENC Fennec Pharmaceuticals Inc.
5.59
-5.89%
KAN.ST Kancera AB (publ)
1.0980
-1.96%
ARTV Artiva Biotherapeutics, Inc.
2.5400
-11.19%